+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030- Product Image
Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030- Product Image
Sale

Contraceptive Pills Market by Formulation, Packaging, Dosage Cycle, Pricing Tier, Distribution Channel, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5716226
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Contraceptive Pills Market grew from USD 20.76 billion in 2024 to USD 22.12 billion in 2025. It is expected to continue growing at a CAGR of 6.50%, reaching USD 30.29 billion by 2030.

Setting the Stage for a Shifting Contraceptive Pill Landscape

The global contraceptive pills market stands at a pivotal juncture, driven by evolving consumer expectations, heightened regulatory scrutiny, and rapid innovation in formulation and delivery. Rising awareness of reproductive health, expanding female workforce participation, and digital transformation in healthcare have all converged to reshape both demand and supply dynamics. Against this backdrop, stakeholders require a distilled yet nuanced overview of key trends, challenges, and strategic imperatives that will define success in the coming years.

This executive summary synthesizes comprehensive primary and secondary research, expert interviews, and rigorous data analysis to equip industry leaders, policymakers, and investors with actionable insights. It frames the most critical shifts in market structure and competitive behavior, examines the cascading effects of recent tariff changes, and highlights segmentation and regional patterns that inform targeted growth strategies. The synthesis prioritizes clarity and relevance, ensuring decision-makers can rapidly identify priority areas without sacrificing analytical depth.

By integrating macroeconomic context with granular segmentation and competitive intelligence, this overview lays the foundation for informed dialogue and strategic planning. The subsequent sections delve into transformative market drivers, regulatory impacts, segmentation breakdowns, regional variations, and recommendations designed to steer organizations toward sustained leadership in an increasingly complex environment.

Unpacking the Transformative Shifts Changing Contraceptive Access and Innovation

Healthcare delivery has undergone a seismic shift as digital channels and telehealth platforms become primary touchpoints for contraceptive counseling and prescription fulfillment. Telemedicine’s surge has eliminated geographical barriers, enabling wider access to both combination and progestin-only formulations. Concurrently, personalized medicine is gaining traction: hormonal profiles, genetic markers, and real-world user data now inform tailored dosage cycles and device integrations to optimize efficacy and adherence.

Innovation in formulation has accelerated, with ultra-low-dose monophasic pills and multiphasic combination variants emerging to mitigate side effects and accommodate diverse patient profiles. Sustainability concerns are also reshaping packaging choices, as manufacturers explore recyclable blister materials and streamlined strip designs to reduce environmental footprints. At the same time, pricing dynamics have shifted, with generic entrants intensifying competition against established branded options, prompting strategic alliances and co-marketing agreements to preserve market share.

Policy reforms and evolving reimbursement frameworks further amplify these transformative trends. Expanded insurance coverage for contraceptive services, coupled with advocacy for over-the-counter access, signals a convergence toward consumer-centric care models. As these forces coalesce, stakeholders must adapt swiftly to maintain relevance and capitalize on new growth vectors within the contraceptive pills landscape.

Assessing the Cumulative Impact of New US Tariffs on Contraceptive Pill Dynamics

The implementation of updated United States tariffs in 2025 has introduced new complexities across the contraceptive pills supply chain. Tariff increases on key raw materials and secondary packaging components have elevated input costs for manufacturers, prompting recalibrations in sourcing strategies and cost pass-through mechanisms. As a result, downstream pricing pressures are emerging, with both branded and generic producers evaluating margin absorption versus selective price adjustments for end-users and payers.

Beyond cost implications, these tariff shifts have reinforced the importance of supply chain resilience. Companies are diversifying supplier networks and accelerating regional production capabilities to mitigate exposure to geopolitical volatility. Inventory management protocols have been overhauled to accommodate longer lead times for imported components, and cross-border logistics strategies now incorporate dynamic routing to minimize tariff liabilities.

In aggregate, the 2025 tariff landscape has catalyzed a reexamination of operational efficiency and strategic sourcing. Organizations that proactively renegotiate supplier contracts, repatriate critical manufacturing processes, and optimize packaging designs stand to buffer margin erosion. The resulting paradigm underscores a broader imperative: adaptability in regulatory environments is as crucial as innovation in product development when shaping the future of contraceptive care.

Unlocking Market Dynamics through Strategic Segmentation Insights

Analyzing market segmentation reveals distinct value drivers across formulation, packaging, dosage cycle, pricing tier, distribution channel, and end-user demographics. In formulation, combination pills dominate, encompassing biphasic, monophasic, triphasic, and quadriphasic variants, with monophasic options further classified into low-dose, standard-dose, and ultra-low-dose formats that cater to evolving safety and tolerability standards. On the packaging front, blister packs retain strong penetration for their convenience and compliance facilitation, while strip packs gain favor in subscription-based delivery models.

Dosage cycle segmentation highlights the ubiquity of 21-day and 28-day regimens, with extended-cycle alternatives attracting niche segments seeking menstrual suppression. Pricing tier analysis underscores a two-fold dynamic: branded products leverage premium positioning through differentiated formulations and marketing investments, whereas generic counterparts compete on cost efficiency and broad formulary access. Distribution channels present multifaceted opportunities; clinic and hospital pharmacies serve traditional patient flows, while online pharmacies amplify reach through telehealth integration. Retail pharmacies, subdivided into chain and independent outlets, remain critical touchpoints for over-the-counter availability.

Demographic segmentation further refines strategic targeting. Adolescents constitute a vital segment for educational initiatives and adherence support, while adults aged 20-34 represent the core user base driving volume and innovation demand. Mature adults, increasingly focused on non-contraceptive benefits such as cycle regulation and hormone-related symptom management, underscore the expanding therapeutic potential. A holistic view of these segmentation dimensions empowers stakeholders to refine product development, marketing strategy, and channel optimization with precision.

Mapping Regional Growth Patterns across Americas, EMEA, and Asia-Pacific

Regional analysis uncovers divergent adoption patterns and growth catalysts across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, high awareness levels and comprehensive insurance frameworks underpin robust demand for both branded and generic formulations. Market maturity fosters consolidation among leading players, while innovation clusters in personalized dosage solutions and digital adherence tools.

In Europe Middle East & Africa, regulatory harmonization under initiatives such as the European Medicines Agency streamlines cross-border product approvals, enhancing market accessibility. However, variations in reimbursement policies and cultural attitudes toward contraception require nuanced market entry strategies that balance cost containment with differentiated value propositions.

Asia-Pacific emerges as the fastest-growing region, propelled by expanding urbanization, rising disposable incomes, and accelerating digital health adoption. E-commerce platforms have become instrumental in widening access, particularly in underserved urban centers. Moreover, increasing government investment in women’s health programs and public-private partnerships amplifies outreach efforts, setting the stage for sustained market expansion.

Profiling Leading Companies Driving Contraceptive Pill Advancements

Competitive landscapes are shaped by a blend of established pharmaceutical conglomerates, agile generic manufacturers, and specialized biotech innovators. Multinational corporations leverage extensive R&D pipelines and global marketing networks to introduce next-generation formulations and secure formulary placements. Concurrently, generic producers capitalize on patent expirations by offering cost-effective alternatives, driving volume growth and intensifying price competition.

Emerging biotech firms bring novel mechanisms of action into early development, exploring hormonal combinations and non-oral delivery systems that promise enhanced user convenience and safety. Strategic partnerships between these innovators and larger commercial entities facilitate accelerated market entry and expanded distribution footprints. Additionally, digital health integrators are forging alliances to embed adherence tracking, real-time feedback, and virtual support services into product offerings, blurring the lines between pharmaceutical and service ecosystems.

These competitive dynamics underscore the importance of agile collaboration, technology integration, and strategic portfolio management. Organizations that balance scale with innovation, and that align product differentiation with evolving consumer preferences, will be best positioned to capture emerging opportunities in the contraceptive pills market.

Actionable Strategies for Industry Leaders to Navigate Evolving Markets

Industry leaders must adopt a multifaceted approach to sustain competitive advantage. First, investing in digital and telehealth infrastructure is paramount to reach consumers through preferred channels and enhance adherence support. Integrating data analytics and user feedback loops into product development pipelines will optimize formulation efficacy and patient satisfaction.

Second, diversifying supply chains by establishing regional manufacturing hubs and forging partnerships with alternative suppliers will build resilience against tariff fluctuations and geopolitical disruptions. Concurrently, embedding sustainable practices in packaging and raw material sourcing can drive cost efficiencies and meet growing environmental expectations.

Lastly, fostering strategic alliances across industry, academia, and public health entities will accelerate innovation and broaden market access. By engaging in policy dialogues and contributing to evidence generation, companies can shape regulatory frameworks in ways that support patient-centric care models. These actionable strategies, pursued in parallel, will enable organizations to navigate complexity and unlock value in an evolving market.

Rigorous Research Methodology Ensuring Robust Market Intelligence

The research draws upon a rigorous mixed-methods approach, combining comprehensive secondary data analysis with targeted primary research. Industry reports, regulatory filings, peer-reviewed literature, and proprietary databases provided the foundation for market mapping, while interviews with key opinion leaders, supply chain stakeholders, and policy experts enriched the contextual understanding.

Data triangulation ensured consistency and validity, with cross-verification of quantitative findings against qualitative insights. A structured segmentation framework guided the dissection of market dimensions, and regional assessments employed standardized criteria to facilitate comparability. Throughout the process, methodological rigor was upheld through peer reviews and quality audits, ensuring that conclusions rest on robust evidence and transparent assumptions.

The result is a thorough analysis that balances breadth and depth, delivering credible insights that withstand scrutiny and support strategic decision-making in the dynamic contraceptive pills market.

Drawing Conclusions to Guide Future Decisions in Contraceptive Pills

This executive summary has outlined the critical forces reshaping the contraceptive pills landscape, from digital transformation and personalized medicine to tariff-driven supply chain recalibrations. Through detailed segmentation and regional analysis, we have identified distinct pathways for market growth and competitive differentiation. The synthesis of competitive insights and actionable recommendations equips stakeholders with a clear roadmap for seizing emerging opportunities and mitigating risks.

As the market continues to evolve, agility, innovation, and strategic collaboration will serve as the cornerstones of sustained leadership. Decision-makers are encouraged to leverage the insights presented here to refine strategies, optimize resource allocation, and maintain a customer-centric focus. By doing so, organizations can position themselves at the forefront of an industry dedicated to advancing reproductive health and empowering individuals worldwide.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Formulation
    • Combination Pill
      • Biphasic
      • Monophasic
        • Low Dose
        • Standard Dose
        • Ultra-Low Dose
      • Quadriphasic
      • Triphasic
    • Progestin-Only Pill
  • Packaging
    • Blister Pack
    • Strip Pack
  • Dosage Cycle
    • 21-Day Regimen
    • 28-Day Regimen
    • Extended Cycle
  • Pricing Tier
    • Branded
    • Generic
  • Distribution Channel
    • Clinic Pharmacy
    • Hospital Pharmacy
    • Online Pharmacy
    • Retail Pharmacy
      • Chain Pharmacy
      • Independent Pharmacy
  • End User
    • Adolescents
    • Adults
      • 20-24
      • 25-29
      • 30-34
    • Mature Adults
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Bayer AG
  • Pfizer Inc.
  • Organon & Co.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Novartis AG
  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Contraceptive Pills Market, by Formulation
8.1. Introduction
8.2. Combination Pill
8.2.1. Biphasic
8.2.2. Monophasic
8.2.2.1. Low Dose
8.2.2.2. Standard Dose
8.2.2.3. Ultra-Low Dose
8.2.3. Quadriphasic
8.2.4. Triphasic
8.3. Progestin-Only Pill
9. Contraceptive Pills Market, by Packaging
9.1. Introduction
9.2. Blister Pack
9.3. Strip Pack
10. Contraceptive Pills Market, by Dosage Cycle
10.1. Introduction
10.2. 21-Day Regimen
10.3. 28-Day Regimen
10.4. Extended Cycle
11. Contraceptive Pills Market, by Pricing Tier
11.1. Introduction
11.2. Branded
11.3. Generic
12. Contraceptive Pills Market, by Distribution Channel
12.1. Introduction
12.2. Clinic Pharmacy
12.3. Hospital Pharmacy
12.4. Online Pharmacy
12.5. Retail Pharmacy
12.5.1. Chain Pharmacy
12.5.2. Independent Pharmacy
13. Contraceptive Pills Market, by End User
13.1. Introduction
13.2. Adolescents
13.3. Adults
13.3.1. 20-24
13.3.2. 25-29
13.3.3. 30-34
13.4. Mature Adults
14. Americas Contraceptive Pills Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Contraceptive Pills Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Contraceptive Pills Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Bayer AG
17.3.2. Pfizer Inc.
17.3.3. Organon & Co.
17.3.4. Johnson & Johnson
17.3.5. Teva Pharmaceutical Industries Ltd.
17.3.6. Viatris Inc.
17.3.7. Novartis AG
17.3.8. Aurobindo Pharma Limited
17.3.9. Sun Pharmaceutical Industries Limited
17.3.10. Cipla Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CONTRACEPTIVE PILLS MARKET MULTI-CURRENCY
FIGURE 2. CONTRACEPTIVE PILLS MARKET MULTI-LANGUAGE
FIGURE 3. CONTRACEPTIVE PILLS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CONTRACEPTIVE PILLS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CONTRACEPTIVE PILLS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CONTRACEPTIVE PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BIPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ULTRA-LOW DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY QUADRIPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY TRIPHASIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PROGESTIN-ONLY PILL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BLISTER PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY STRIP PACK, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 21-DAY REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 28-DAY REGIMEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY EXTENDED CYCLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY BRANDED, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY GENERIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CLINIC PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADOLESCENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 20-24, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 25-29, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY 30-34, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CONTRACEPTIVE PILLS MARKET SIZE, BY MATURE ADULTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CONTRACEPTIVE PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 68. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 69. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 70. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 71. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 72. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 74. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. CANADA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 76. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 77. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 78. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 119. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 127. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 129. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 137. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 138. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 139. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 141. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 142. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 147. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 148. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 149. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 157. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 158. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 159. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 160. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 161. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 162. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 163. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 165. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. ITALY CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 167. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 168. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 169. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 175. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 177. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 187. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 188. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 189. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 197. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 198. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 199. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 207. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 208. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 209. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 213. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 215. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 216. DENMARK CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 217. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 218. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 219. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 227. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 228. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 229. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 230. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 231. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 232. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 233. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 235. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. QATAR CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 237. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 238. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 239. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 240. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 241. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 242. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 247. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 248. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 249. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 257. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 258. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 259. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 267. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 268. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 269. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 272. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 273. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 275. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. EGYPT CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 277. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 278. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 279. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 280. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 281. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 282. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 283. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 284. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 285. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 286. TURKEY CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 287. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 288. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 289. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 290. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 291. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 292. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 293. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 294. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 295. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 296. ISRAEL CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 297. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 298. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 299. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 300. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 301. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 302. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 303. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 305. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. NORWAY CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 307. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 308. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 309. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 310. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 311. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 312. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 313. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 314. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 315. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 316. POLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 317. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 318. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 319. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 320. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 321. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 322. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 323. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 324. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 325. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 326. SWITZERLAND CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 327. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 328. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 329. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 330. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 331. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 332. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 333. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 334. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 336. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY ADULTS, 2018-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC CONTRACEPTIVE PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 338. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 339. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY COMBINATION PILL, 2018-2030 (USD MILLION)
TABLE 340. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY MONOPHASIC, 2018-2030 (USD MILLION)
TABLE 341. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PACKAGING, 2018-2030 (USD MILLION)
TABLE 342. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DOSAGE CYCLE, 2018-2030 (USD MILLION)
TABLE 343. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY PRICING TIER, 2018-2030 (USD MILLION)
TABLE 344. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 345. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY RETAIL PHARMACY, 2018-2030 (USD MILLION)
TABLE 346. CHINA CONTRACEPTIVE PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 347. CH

Companies Mentioned

The companies profiled in this Contraceptive Pills market report include:
  • Bayer AG
  • Pfizer Inc.
  • Organon & Co.
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.
  • Novartis AG
  • Aurobindo Pharma Limited
  • Sun Pharmaceutical Industries Limited
  • Cipla Limited

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.12 Billion
Forecasted Market Value ( USD ) by 2030 $ 30.29 Billion
Compound Annual Growth Rate6.5%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Contraceptive Market - Global Forecast to 2030 - Product Image

Contraceptive Market - Global Forecast to 2030

  • Report
  • 184 Pages
  • Global
From
Oral Contraceptive Pills Market by Product Type, Formulation, Dosage Strength, Brand, Distribution Channel - Global Forecast to 2030 - Product Image

Oral Contraceptive Pills Market by Product Type, Formulation, Dosage Strength, Brand, Distribution Channel - Global Forecast to 2030

  • Report
  • 194 Pages
  • Global
From
Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Contraceptive Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • 150 Pages
  • Global
From
Oral Contraceptive Pills Market Report 2025 - Product Image

Oral Contraceptive Pills Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Emergency Contraceptive Pills Market 2025-2033 - Product Image

Emergency Contraceptive Pills Market 2025-2033

  • Report
  • 142 Pages
  • Global
From

About the Birth Control Pill Market

The Birth Control Pill is a form of contraception used by women to prevent pregnancy. It is a hormonal medication taken orally, usually once a day, and works by preventing ovulation and fertilization. It is one of the most popular forms of contraception in the world, and is widely used by women of all ages. The Birth Control Pill is an important part of Women's Health, as it provides women with the ability to control their reproductive health and plan their families. It is also used to treat a variety of medical conditions, such as endometriosis, polycystic ovary syndrome, and acne. The Birth Control Pill market is highly competitive, with many companies offering different types of pills. Some of the major players in the market include Bayer, Pfizer, Merck, and Teva Pharmaceuticals. Other companies include Mylan, Allergan, and Actavis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.